Balsalazide
Balsalazide is an aminosalicylate anti-inflammatory used to treat mildly to moderately active ulcerative colitis in adults and children as young as 5 years old.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 9 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Balsalazide: Patient Information Guide
A plain-language walkthrough of Balsalazide — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Balsalazide is an aminosalicylate used to reduce inflammation in the colon. Here are the conditions it is approved to treat:
- Mildly to moderately active ulcerative colitis in adults — treatment is typically for up to 12 weeks based on clinical trial data (Balsalazide Disodium and Colazal capsules)
- Mildly to moderately active ulcerative colitis in children and adolescents ages 5 through 17 — treatment is approved for up to 8 weeks (Balsalazide Disodium and Colazal capsules)
⚙️How it works▾
Balsalazide is what's called a prodrug — it's designed to pass through the stomach and small intestine intact, without being broken down. Once it reaches the colon, bacteria there cleave the molecule and release mesalamine (also called 5-ASA), which is the part that actually fights inflammation. Mesalamine works locally on the colon's lining, likely by blocking the production of inflammatory chemicals (arachidonic acid metabolites) that are overactive in ulcerative colitis. Because the action is mostly local — not systemic — only a small amount of the drug enters the bloodstream.
💊How it's taken▾
Balsalazide disodium capsules are taken by mouth three times daily, and can be taken with or without food. Capsules should be swallowed whole; if swallowing is difficult, the capsule contents can be sprinkled on applesauce and eaten right away. Treatment in adults typically lasts up to 8 weeks, with some patients in trials continuing up to 12 weeks. In children ages 5–17, treatment is for up to 8 weeks. Always follow your prescriber's exact instructions regarding how many capsules to take and for how long.
- Can be taken with or without food
- Drink plenty of fluids throughout treatment
- Do not cut, crush, break, or chew capsules
- If opening capsules to sprinkle, use applesauce — consume the mixture immediately, do not save it
🤒Side effects — in detail▾
The most common side effects reported in clinical trials include:
- Headache
- Abdominal pain
- Diarrhea
- Nausea and vomiting
- Respiratory infections
- Joint pain (arthralgia)
- Fatigue
- Gas (flatulence) and indigestion
Children in clinical trials reported similar side effects, plus upper abdominal pain and fever more frequently. Serious reactions — including kidney damage, severe skin reactions, liver problems, and heart inflammation — are rare but require prompt medical attention if they occur.
⚠️Warnings & precautions▾
- Kidney damage: Balsalazide can cause kidney inflammation or failure in rare cases. Kidney function should be checked before starting and monitored during treatment. Stop the medication if kidney function worsens.
- Kidney stones: Stones made of mesalamine can form and are invisible on standard X-rays or CT scans. Staying well hydrated helps reduce this risk.
- Intolerance syndrome: A small number of patients develop worsening cramps, bloody diarrhea, fever, or rash — symptoms that can mimic a colitis flare but are actually a reaction to the drug. Stop the medication and contact your doctor if this happens.
- Serious skin reactions: Rare but life-threatening skin conditions (Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, AGEP) have been reported. Stop the medication at the first sign of blistering, peeling, or a spreading rash.
- Heart inflammation: Myocarditis (heart muscle inflammation) and pericarditis (inflammation around the heart) have been reported. Seek immediate care for chest pain or palpitations.
- Liver problems: Liver failure has occurred in patients with pre-existing liver disease. Tell your doctor about any liver conditions before starting.
- Photosensitivity: Patients with pre-existing skin conditions like eczema may be more sensitive to sunlight. Use sunscreen and protective clothing when outdoors.
- Older adults: People 65 and older may have a higher risk of blood cell abnormalities (low white blood cells or platelets) — blood counts should be monitored.
🔀What it interacts with▾
Balsalazide can interact with certain other medications. Let your doctor and pharmacist know about everything you take:
- NSAIDs (ibuprofen, naproxen, etc.): Combining these with balsalazide raises the risk of kidney damage — kidney function should be monitored closely
- Azathioprine or 6-mercaptopurine: These immune-suppressing drugs, sometimes used for inflammatory bowel disease, can increase the risk of serious blood disorders and bone marrow problems when combined with balsalazide — blood counts should be checked regularly
- Other nephrotoxic drugs (medications known to stress the kidneys): Increased risk of kidney damage — monitor kidney function
- Urinary normetanephrine lab test: Balsalazide's metabolite can interfere with this urine test and produce falsely high results — tell your lab or doctor you're taking this medication if this test is ordered
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Allergy to salicylates, aminosalicylates, or sulfasalazine: Do not take balsalazide — it is contraindicated if you have a known or suspected hypersensitivity to these
- Kidney disease or reduced kidney function: Use with caution; kidney function must be assessed before starting and monitored during treatment
- Liver disease: Discuss risks and benefits with your doctor before starting, as liver failure has been reported in patients with pre-existing liver problems
- Upper GI obstruction or pyloric stenosis: Avoid balsalazide — a blockage in the upper digestive tract can prevent the drug from reaching the colon where it works
- Pregnancy: Available data have not shown a clear link between mesalamine and birth defects, but uncontrolled ulcerative colitis itself carries risks in pregnancy — discuss with your doctor
- Breastfeeding: Mesalamine passes into breast milk in small amounts; watch for diarrhea in the nursing infant and consult your doctor
- Children under 5: Safety and effectiveness have not been established for this age group
- Adults 65 and older: Higher risk of blood cell abnormalities — complete blood counts and platelet counts should be monitored
- Pre-existing skin conditions (eczema, atopic dermatitis): May be more prone to severe photosensitivity — use sunscreen and protective clothing
🚑If you take too much▾
Taking too much balsalazide may cause symptoms similar to salicylate (aspirin-type) toxicity: nausea, vomiting, abdominal pain, ringing in the ears, rapid breathing, dizziness, confusion, or seizures. Severe overdose can affect electrolyte balance and may harm the kidneys or liver. There is no specific antidote — seek emergency medical care immediately if an overdose is suspected.
📡Pharmacodynamics — effects in the body▾
Balsalazide is converted in the colon to mesalamine (5-ASA), which acts locally on the colon's inner lining to reduce inflammation. Mesalamine appears to work by blocking the production of inflammatory chemicals — specifically arachidonic acid metabolites produced through both the cyclooxygenase and lipoxygenase pathways — which are overactive in people with ulcerative colitis. Because the drug acts locally rather than throughout the body, systemic exposure is minimal.
🔬Pharmacokinetics — how your body processes it▾
Balsalazide is designed to be acid-insoluble, so it passes through the stomach and small intestine essentially intact and reaches the colon as a prodrug. Once there, bacteria break it down into mesalamine (5-ASA) and an inert carrier molecule; mesalamine is then further metabolized into N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA). Only a small amount of the drug and its metabolites is absorbed into the bloodstream — most of the therapeutic action is local. The majority of the drug is recovered in the feces; a small fraction is excreted in the urine. Eating a high-fat meal before taking the capsules can reduce and delay absorption, though this likely has little impact on how well the drug works since its effects are primarily local in the colon.
📦How to store it▾
Store at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted between 15ºC and 30ºC (59ºF and 86ºF).
📄 Written from Balsalazide’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Balsalazide
17 supplements and herbal products have documented interactions with Balsalazide in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 7
- Minor · 9
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Balsalazide — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is balsalazide and what does it do for ulcerative colitis? ▾
Can I open the capsule if I have trouble swallowing it? ▾
What side effects should I expect, and when should I call my doctor? ▾
Does it matter if I take this with food or on an empty stomach? ▾
Is it safe to take if I'm pregnant or breastfeeding? ▾
Are there any medications I should avoid while taking balsalazide? ▾
Is Balsalazide available over the counter? ▾
When was Balsalazide first available? ▾
Who makes Balsalazide? ▾
💬 Answers drafted from Balsalazide’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Balsalazide comes
Balsalazide is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Capsule
How this form is used
- Balsalazide Disodium capsules are used to treat mildly to moderately active ulcerative colitis in adults and in children ages 5 through 17
- Colazal capsules are used to treat mildly to moderately active ulcerative colitis in adults and in children ages 5 through 17
- Balsalazide Disodium capsules should be swallowed whole; do not cut, crush, break, or chew them
- Balsalazide Disodium capsules may be opened and sprinkled on a small amount of applesauce for patients who cannot swallow capsules — the mixture must be chewed and swallowed immediately and not stored
- Balsalazide Disodium capsules can be taken with or without food
- Balsalazide Disodium capsules require adequate fluid intake throughout treatment to help reduce the risk of kidney stones
📊 Balsalazide across the U.S. market
How Balsalazide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (9) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Balsalazide is used
A general measure of how commonly Balsalazide is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Balsalazide is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Balsalazide prescribed? Of the 1,596 medications we measure, Balsalazide ranks #949 by Medicaid prescriptions — more than 41% of them.
Utilization by Balsalazide product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
balsalazide disodium 750 MG Oral Capsule
Summed across the 3 of 18 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 885857
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Balsalazide, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 3 of 18 listed Balsalazide NDCs with Medicaid activity.
🔍 Compare Balsalazide products
A representative set of FDA-listed product records for Balsalazide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 750 mg | Oral | Apotex Corp. × 3 listings | ANDA | View NDC → |
| 750 mg | Oral | AvPAK × 2 listings | ANDA | View NDC → |
| 750 mg | Oral | Bryant Ranch Prepack × 3 listings | ANDA | View NDC → |
| 750 mg | Oral | Carnegie Pharmaceuticals, LLC | ANDA | View NDC → |
| 750 mg | Oral | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 750 mg | Oral | Hikma Pharmaceuticals USA Inc. × 3 listings | ANDA | View NDC → |
| 750 mg | Oral | Oceanside Pharmaceuticals | NDA AUTHORIZED GENERIC | View NDC → |
| 750 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 750 mg | Oral | Salix Pharmaceuticals, Inc | NDA AUTHORIZED GENERIC | View NDC → |
| 750 mg | Oral | Salix Pharmaceuticals, Inc | NDA | View NDC → |
| 750 mg | Oral | Zydus Lifesciences Limited × 2 listings | ANDA | View NDC → |
| 750 mg | Oral | Zydus Pharmaceuticals (USA) Inc. × 2 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Formosa Laboratories, Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | PharmaZell GmbH × 2 listings | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | PharmaZell GmbH × 5 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Signa S.A. de C.V. | BULK INGREDIENT | View NDC → |
Showing 33 of 33 products — FDA National Drug Code Directory. See every product, package size and price: browse all 33 Balsalazide NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Balsalazide — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Balsalazide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Balsalazide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 18747 2 dose forms · 2 strengths
-
Dose form (SCDF) Oral Capsule RxCUI 374634In current FDA listingsClinical drug / strength (SCD) disodium 750 MGRxCUI 885857 -
Dose form (SCDF) Oral Tablet RxCUI 1243576No current FDA listingClinical drug / strength (SCD) disodium 1100 MGRxCUI 1243577
Look up RxCUI 18747 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Balsalazide is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Balsalazide belongs to the Aminosalicylate class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 9 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Hikma Pharmaceuticals USA Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.